Antimicrobial Matrix for Percutaneous Device Access Sites
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current antimicrobial dressings for percutaneous devices are limited by hypersensitivity reactions, cytotoxicity, dermal discoloration, and gaps between the dressing and the device, which can lead to infections and are not suitable for pediatric use or optimal moisture management.
Innovation Solution
A matrix-based antimicrobial article with a three-dimensional contact mode, incorporating a silver-containing antimicrobial agent for sustained release, which minimizes gaps with the device, manages moisture, and is non-toxic and non-irritating, featuring a hydrophilic matrix with passages for optimal interaction with the percutaneous device access site.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If chlorhexidine gluconate is used as antimicrobial agent, then catheter-related bloodstream infection is reduced by 60%, but hypersensitivity reactions occur and it is not safe for pediatric applications
Solution Approach 1:
The patent changes the antimicrobial agent from chlorhexidine gluconate to silver-containing compounds (such as silver nitrate, silver sulfate, or silver chloride), fundamentally altering the chemical parameter while maintaining antimicrobial efficacy. This substitution resolves the hypersensitivity and pediatric safety issues associated with chlorhexidine while preserving infection prevention capabilities.
Solution Approach 2:
The patent employs a composite matrix system combining silver-containing compounds with hydrophilic polymers and moisture management materials. This composite structure enables sustained silver release while providing moisture balance, resolving the contradiction between effective antimicrobial action and safety profile.
2Reliability
If silver ions are released from dressing, then antimicrobial barrier activity is provided, but dermal discoloration and cytotoxicity occur
Solution Approach 1:
The patent carefully controls the release parameters of silver ions through the hydrophilic matrix system, regulating concentration and release rate to maintain antimicrobial efficacy while preventing dermal discoloration and cytotoxicity. The matrix structure modifies the physical and chemical parameters of silver delivery.
Solution Approach 2:
The patent applies silver-containing compounds locally at the wound site through controlled release from the matrix, concentrating antimicrobial activity where needed while minimizing systemic absorption and associated toxicity. The localized delivery mechanism reduces harmful effects at distant sites.
3Ease of operation
If point or two-dimensional contact dressings are used, then simple application is achieved, but gaps remain between dressing and device exposing access site to pathogens
Solution Approach 1:
The patent transitions from point or two-dimensional contact to three-dimensional contact by incorporating a protruding portion that extends toward the percutaneous device. This dimensional change creates overlapping contact areas, eliminating gaps and enhancing protection while maintaining ease of application through the self-adhering matrix structure.
4Reliability
If dressings absorb fluid, then moisture management is improved, but excessive absorption may cause dermal drying and compromise healing
Solution Approach 1:
The patent modifies the moisture management parameters by incorporating hydrophilic polymers that regulate fluid absorption and release. The matrix structure controls the rate and amount of fluid absorption, preventing excessive uptake that would cause dermal drying while maintaining optimal moisture levels for healing.
Solution Approach 2:
The hydrophilic matrix system provides feedback control for moisture management, dynamically adjusting fluid absorption and release based on wound conditions. This feedback mechanism ensures optimal moisture balance without causing dermal drying or compromising the healing process.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The article effectively reduces infections by providing broad-spectrum antimicrobial protection for up to seven days, maintains optimal moisture balance, and is less likely to cause hypersensitivity or discoloration, while absorbing exudates and providing hydration to dry sites.
Implementation Method 1
The first passage extends from an edge of the matrix toward an internal point of the article. The second passage connects with the first passage at one end of the first passage. At least a portion of a second passage comprises a curved shape.
Implementation Method 2
the antimicrobial article of the present invention may donate moisture to a dry dermal site (e.g., a dry wound bed) and/or absorb liquid or exudates of a dermal site
Data Source
Figure 1
Figure 2
AI summary
ANTIMICROBIAL SITE DRESSING ABSTRACT The present invention comprises antimicrobial articles for use with a percutaneous device, comprising a matrix which may contact the percutaneous device in a three-dimensional mode and release antimicrobial agents (e.g., silver ions) to the percutaneous device access site. In addition, the antimicrobial article of the present invention may donate moisture to a dry dermal site (e.g., a dry wound bed) and/or absorb liquid or exudates of a dermal site. The present invention also comprises methods for treating and/or preventing an infection using the antimicrobial articles of the present invention.